Congo to begin Ebola vaccinations on Monday
By Benoit Nyemba MBANDAKA, Democratic Republic of Congo (Reuters) – Health workers in...
Read MoreMay 20, 2018
By Benoit Nyemba MBANDAKA, Democratic Republic of Congo (Reuters) – Health workers in...
Read MoreMay 18, 2018
By Tom Miles and Fiston Mahamba GENEVA/KINSHASA (Reuters) – The Ebola outbreak in Democratic...
Read MoreMay 18, 2018
By Roberta Rampton WASHINGTON (Reuters) – U.S. President Donald Trump on Friday issued a...
Read MoreMay 18, 2018
By Ben Hirschler LONDON (Reuters) – U.S. and European regulators said they were assessing...
Read MoreMay 18, 2018
By Rod Nickel and P.J. Huffstutter (Reuters) – Cargill, the global grains trader, sees the...
Read MoreMay 18, 2018
By Tamara Mathias (Reuters) – Agile Therapeutics Inc’s shares sank 75 percent on...
Read MoreMay 18, 2018
By Lisa Rapaport (Reuters Health) – Public reporting of outcomes for a common procedure to clear blocked arteries was supposed to improve quality, but some doctors say it hasn’t delivered on the goal of enhancing...
Read MoreMay 18, 2018
By Mary Gillis (Reuters Health) – Most of the top diabetes treatment centers in the U.S. provide experts in hormonal disease, diet and nutrition and diabetes education as part of normal care, but mental health support is...
Read MoreMay 17, 2018
By Deena Beasley (Reuters) – Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults. The drug, Aimovig, which is given...
Read MoreMay 17, 2018
By Michael Erman (Reuters) – The U.S. Food and Drug Administration on Thursday listed a...
Read MoreMay 17, 2018
By Patient Ligodi and Benoit Nyemba KINSHASA (Reuters) – Congolese and U.N. officials were...
Read MoreMay 17, 2018
By Ludwig Burger FRANKFURT (Reuters) – Germany’s Merck KGaA said two of its...
Read MoreMay 17, 2018
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Loxo Oncology Inc drug that targets cancers with mistakes in the RET gene led to tumor shrinkage in nearly 70 percent of patients regardless of where their cancer...
Read MoreMay 17, 2018
GENEVA/KINSHASA (Reuters) – The first batch of 4,000 experimental Ebola vaccines to combat...
Read MoreMay 16, 2018
By Julie Steenhuysen CHICAGO (Reuters) – Testing advanced lung cancer patients for all of the possible genetic mutations that could be driving their cancer at once is more cost effective than testing for one or a limited...
Read MoreMay 16, 2018
(Reuters) – The U.S. Food & Drug Administration said on Wednesday it found inaccuracies in sales data of opioid drug products provided by IQVIA Holdings Inc, a vendor it contracts. The regulator said IQVIA...
Read MoreMay 16, 2018
By Stine Jacobsen and Arno Schuetze COPENHAGEN/FRANKFURT (Reuters) – Hearing aid makers...
Read MoreMay 15, 2018
(Reuters) – Planned Parenthood and the American Civil Liberties Union’s Iowa branch...
Read MoreMay 15, 2018
By Tina Bellon NEW YORK (Reuters) – Litigation against OxyContin maker Purdue Pharma LP is...
Read MoreMay 15, 2018
By Tamara Mathias and Manas Mishra (Reuters) – Pfizer Inc’s Retacrit was approved by...
Read More